A multinational clinical trial led by UT Southwestern Medical Center and others found that injection of a new long-acting insulin combined with another drug improves glucose control in patients with Type 2 diabetes and, additionally, is associated with weight loss.

from News-Medical.Net Weight Loss News Feed http://ift.tt/1QqPOYW
Follow Us on Twitter
Follow Us on FB
Follow Us on Pinterest
Follow Us on G+
Follow Us on Instagram
Follow Us on Instagram
Follow Us on Delicious
Follow Us on Wordpress

An estimated 126.6 million Americans (one in two adults) are affected by a musculoskeletal condition--comparable to the total percentage of Americans living with a chronic lung or heart condition--costing an estimated $213 billion in annual treatment, care and lost wages, according to a new report issued today by the United States Bone and Joint Initiative.

from News-Medical.Net Weight Loss News Feed http://ift.tt/1Y07PCu
Follow Us on Twitter
Follow Us on FB
Follow Us on Pinterest
Follow Us on G+
Follow Us on Instagram
Follow Us on Instagram
Follow Us on Delicious
Follow Us on Wordpress

More than two-thirds of all type-2 diabetes patients do not achieve good control of their disease with the first-line medication metformin combined with second-line insulin shots.

from News-Medical.Net Weight Loss News Feed http://ift.tt/1RFINWH
Follow Us on Twitter
Follow Us on FB
Follow Us on Pinterest
Follow Us on G+
Follow Us on Instagram
Follow Us on Instagram
Follow Us on Delicious
Follow Us on Wordpress